Treatment of Moderate to Severe Lateral Canthal Lines
common.study.values.description
“Treatment of Moderate to Severe Lateral Canthal Lines”
The objective of the study is to evaluate the efficacy and safety of a single dose of QM1114-DP compared to placebo for the treatment of moderate to severe LCL.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Biological - botulinum toxin
neuromodulator
Biological - Placebo
placebo
participant.views.study.view.additional
participant.views.study.view.scientific-title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Lateral Canthal Lines
common.study.values.clinical-trial-id
NCT04249687
participant.views.study.view.id
dR6Z0d
